The 11% compound share price fall over three years is justif...
The 11% compound share price fall over three years is justified by fundamental deterioration. Uncertainty looms over future profitability without more cash. Last year's performance indicates unresolved challenges, worse than the annualised loss of 0.3% over the last half decade. Investors should heed 2 warning signs.
Further Weakness as Jiangsu Sihuan Bioengineering (SZSE:000518) Drops 15% This Week, Taking Three-year Losses to 37%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment